Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,601–5,625 of 27,380 studies, newest first · page 225 of 1096.

January 2025 25

  1. 2025-01-09

    Pragmatic algorithm for visual assessment of 4-Repeat tauopathies in [18F]PI-2620 PET Scans

    ✓ Peer-reviewed Brain scans and imaging NeuroImage

    Key finding: Patients with 4R-tauopathies in contrast to non-4R-tauopathies were detected at higher sensitivity in the 20-40-minute frame (common: 79%, scaled: 76%) compared to the 40-60-minute frame (common: 55%, scaled: 62%), albeit with reduced specificity in the common setting (20-40-min: 78%, 40-60-min: 95%), which was ameliorated in the intensity-scaled setting (20-40-min: 91%, 40-60-min: 96%). +4 more findings

  2. 2025-01-09

    Multivariate proteome-wide association study to identify causal proteins for Alzheimer disease

    ✓ Peer-reviewed Genetics American journal of human genetics

    Key finding: Here, we aim to identify causal plasma proteins for AD, shedding light on the etiology of AD. +4 more findings

  3. 2025-01-09
  4. 2025-01-09

    Effectiveness of a home-based computerized cognitive training in Parkinson's disease: a pilot randomized cross-over study

    ✓ Peer-reviewed Prevention trials Frontiers in Psychology

    Key finding: These findings suggest that HB-CCT via Neurotablet can effectively enhance specific cognitive abilities in PD, supporting the role of digital, home-based interventions as feasible strategies to mitigate cognitive decline. +3 more findings

  5. 2025-01-09

    Early‐Life Adversity Predicts Markers of Aging‐Related Neuroinflammation, Neurodegeneration, and Cognitive Impairment in Women

    ✓ Peer-reviewed Inflammation and the immune system Annals of Neurology

    Key finding: Analyses revealed significant nonlinear interaction effects of ELS severity and age on NfL and GFAP serum concentrations, total and subcortical gray matter volume loss, increased third ventricular volume, and cognitive impairment. +2 more findings

  6. 2025-01-09
  7. 2025-01-09

    Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in individuals with dementia

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in Neurology

    Key finding: Our studies showed that DC and DRs in VD and AD groups were significantly lower than those in controls, while AC values were significantly higher. +4 more findings

  8. 2025-01-09

    The potential role of machine learning and deep learning in differential diagnosis of Alzheimer’s disease and FTD using imaging biomarkers: A review

    ✓ Peer-reviewed Digital health tools The Neuroradiology Journal

    Key finding: IntroductionThe prevalence of neurodegenerative diseases has significantly increased, necessitating a deeper understanding of their symptoms, diagnostic processes, and prevention strategies. +1 more finding

  9. 2025-01-09
  10. 2025-01-09

    Association of Medial Temporal Lobe Cerebrovascular Reactivity and Memory Function in Older Adults With and Without Cognitive Impairment

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Deficits in medial temporal CVR are observed in older adults with MCI and are related to worse memory function. +3 more findings

  11. 2025-01-09

    Anterior-temporal network hyperconnectivity is key to Alzheimer’s disease: from ageing to dementia

    ✓ Peer-reviewed Getting a diagnosis Brain

    Key finding: Our findings revealed distinct patterns of connectivity linked to normal ageing or Alzheimer's disease. +2 more findings

  12. 2025-01-09

    Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study

    ✓ Peer-reviewed Prevention and risk The Journal of Prevention of Alzheimer s Disease

    Key finding: The study sample included 1,375 participants free of dementia and stroke at baseline (mean age 68 ± 6y, 54 % females). +4 more findings

  13. 2025-01-09

    Environmental factors inducing gastric cancer: insights into risk and prevention strategies

    ✓ Peer-reviewed Prevention and risk Discover Oncology

    Key finding: Gastric cancer, a prevalent malignant tumor worldwide, poses a significant challenge to global health. +1 more finding

  14. 2025-01-09

    Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications

    ✓ Peer-reviewed Prevention and risk Antioxidants

    Key finding: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly increases the risk of cardiovascular disease, which is the leading cause of morbidity and mortality among diabetic patients.

  15. 2025-01-09

    Alzheimer disease: Mechanism and treatments

    ✓ Peer-reviewed Treatments Theoretical and Natural Science

    Key finding: There are also monoclonal antibody drugs that are more directly directed against plaques. +4 more findings

  16. 2025-01-08

    Transcription Factor-Wide Association Studies to Identify Functional SNPs in Alzheimer's Disease

    ✓ Peer-reviewed Genetics The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: While genome-wide association studies (GWAS) have revealed genomic variants linked to AD, their translational impact has been limited due to challenges in interpreting the identified genetic associations.

  17. 2025-01-08
  18. 2025-01-08

    Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities

    ✓ Peer-reviewed Treatments AJNR. American journal of neuroradiology

    Key finding: On the basis of consensus discussion within an expanded American Society of Neuroradiology (ASNR) Alzheimer, ARIA, and Dementia Study Group, our purpose is the following: 1) summarize the FDA guidelines for the evaluation of radiographic ARIA; 2) review the 3 key MRI sequences for ARIA monitoring and standardized imaging protocols on the basis of ASNR-industry collaborations; 3) provide imaging recommendations for 3 key patient scenarios; 4) highlight the role of the radiologist in the care team for this population; 5) discuss implementation of MRI protocols to detect ARIA in diverse practice settings; and 6) present the results of the 2023 ASNR international neuroradiologist practice survey on dementia and ARIA imaging.

  19. 2025-01-08
  20. 2025-01-08

    Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights

    ✓ Peer-reviewed Health systems and care delivery Pharmaceuticals (Basel, Switzerland)

    Key finding: Initially, the clinical adoption of FBB PET faced significant barriers, including reimbursement challenges and uncertainties regarding its integration into diagnostic clinical practice.

  21. 2025-01-08

    A relational approach to co-create Advance Care Planning with and for people living with dementia: a narrative study

    ✓ Peer-reviewed Caregiving BMC Palliative Care

    Key finding: The Shifting Expectations narrative indicated that PwD's needs shifted to co-constructed needs with their family as PwD's independence declined. +4 more findings

  22. 2025-01-08

    Understanding Challenges and Emotions of Informal Caregivers of General Older Adults and People With Alzheimer Disease and Related Dementia: Comparative Study

    ✓ Peer-reviewed Caregiving Journal of Medical Internet Research

    Key finding: In total, 3028 posts were retrieved, including 1552 from older adult-related subreddits and 1476 from Alzheimer disease-related subreddits; 18 key topics were identified, with the most frequent topics being expressing feelings (2178/3028, 71.93%) and seeking advice and support (1982/3028, 65.46%). +4 more findings

  23. 2025-01-08

    Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK

    ✓ Peer-reviewed Prevention and risk Nature Communications

    Key finding: Alcohol (relative risk per 20 g/day=1.15, 95% confidence interval 1.09-1.20) and calcium (per 300 mg/day=0.83, 0.77-0.89) intakes had the strongest associations, followed by six dairy-related factors associated with calcium. +2 more findings

  24. 2025-01-08

    Development and Validation of a Tool to Predict Onset of Mild Cognitive Impairment and Alzheimer Dementia

    ✓ Peer-reviewed Treatments JAMA Network Open

    Key finding: Among the 1665 AIBL participants (741 [44.5%] female) and 2029 ADNI participants (925 [45.6%] female), the mean (SD) age at first evaluation was 71.8 (7.1) years and 74.5 (6.7) years, respectively. +4 more findings

  25. 2025-01-08

    Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders

    ✓ Peer-reviewed Genetics JAMA Psychiatry

    Key finding: Expression profiles of amacrine cells (interneurons within the retina) were robustly enriched in schizophrenia genetic risk across mammalian species and in different developmental stages. +4 more findings

Browse the library by subject, with the full score breakdown →